1451 - 1475 of 8819 Results
Title
Year
-
OPENTitle: Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson’s Disease PatientJournal Name: CellsPublisher: MDPI AGVol: 12Issue #: 4Start Page: 625End Page: 625Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells12040625Best OA location URL: https://www.mdpi.com/2073-4409/12/4/625/pdf?version=1676960152Citation Count: 44
-
OPENTitle: Sex-Specific Microglial Responses to Glucocerebrosidase Inhibition: Relevance to GBA1-Linked Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 12Issue #: 3Start Page: 343End Page: 343Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/cells12030343Best OA location URL: https://www.mdpi.com/2073-4409/12/3/343/pdf?version=1674009937Citation Count: 21
-
OPENTitle: High-speed imaging reveals the bimodal nature of dense core vesicle exocytosisJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 120Issue #: 1Start Page: e2214897120End Page: e2214897120Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2214897120Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9910497Citation Count: 6
-
OPENTitle: Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility StudyJournal Name: American Journal of Speech-Language PathologyPublisher: American Speech Language Hearing AssociationVol: 31Issue #: 6Start Page: 2741End Page: 2758Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1044/2022_ajslp-22-00063Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9911128Citation Count: 19
-
OPENTitle: Data Archive for the BRAIN Initiative (DABI)Journal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 83End Page: 83Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-023-01972-zBest OA location URL: https://doi.org/10.1038/s41597-023-01972-zCitation Count: 22
- Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain Changes2022OPENTitle: Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain ChangesJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 1Start Page: 93End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223527Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223527?id=journal-of-parkinsons-disease%2Fjpd223527Citation Count: 18
-
OPENTitle: Pharmacokinetics and Comparative Bioavailability of Apomorphine Sublingual Film and Subcutaneous Apomorphine Formulations in Patients with Parkinson’s Disease and “OFF” Episodes: Results of a Randomized, Three-Way Crossover, Open-Label StudyJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 693End Page: 709Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00251-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00251-6.pdfCitation Count: 23
-
OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 11
-
OPENTitle: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01282-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01282-8Citation Count: 185
-
OPENTitle: COVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001104Best OA location URL: https://nn.neurology.org/content/nnn/9/1/e1104.full.pdfCitation Count: 37
-
OPENTitle: Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult miceJournal Name: Transgenic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 6Start Page: 867End Page: 873Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11248-021-00286-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11248-021-00286-3.pdfCitation Count: 3
-
OPENTitle: Silica-coated magnetic-nanoparticle-induced cytotoxicity is reduced in microglia by glutathione and citrate identified using integrated omicsJournal Name: Particle and Fibre ToxicologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12989-021-00433-yBest OA location URL: https://particleandfibretoxicology.biomedcentral.com/track/pdf/10.1186/s12989-021-00433-yCitation Count: 18
-
OPENTitle: The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 11Issue #: 11Start Page: 1685End Page: 1685Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom11111685Best OA location URL: https://www.mdpi.com/2218-273X/11/11/1685/pdf?version=1636779345Citation Count: 7
- Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease2021OPENTitle: Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00250-2Best OA location URL: https://www.nature.com/articles/s41531-021-00250-2.pdfCitation Count: 15
-
OPENTitle: Mutations in Parkinsonism-linked endocytic proteins synaptojanin1 and auxilin have synergistic effects on dopaminergic axonal pathologyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 26End Page: 26Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00465-5Best OA location URL: https://www.nature.com/articles/s41531-023-00465-5.pdfCitation Count: 22
-
OPENTitle: Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's diseaseJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 24Issue #:Start Page: 100817End Page: 100817Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100817Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100817Citation Count: 20
-
OPENTitle: Stability Evaluation of Brain Changes in Parkinson's Disease Based on Machine LearningJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2021.735991Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncom.2021.735991/pdfCitation Count: 9
-
OPENTitle: Mitochondrial Defects in Fibroblasts of Pathogenic MAPT PatientsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2021.765408Best OA location URL: https://doi.org/10.3389/fcell.2021.765408Citation Count: 5
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease2021OPENTitle: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2583End Page: 2594Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28706Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28706Citation Count: 106
-
OPENTitle: Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.729635Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.729635/pdfCitation Count: 15
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial2021OPENTitle: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2408End Page: 2412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28702Best OA location URL: https://doi.org/10.1002/mds.28702Citation Count: 16
-
OPENTitle: Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00476-2Best OA location URL: https://www.nature.com/articles/s41531-023-00476-2.pdfCitation Count: 14
-
OPENTitle: Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseasesJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 55Issue #: 3Start Page: 377End Page: 388Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41588-023-01300-6Best OA location URL: https://www.nature.com/articles/s41588-023-01300-6.pdfCitation Count: 172
- Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats2022OPENTitle: Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in ratsJournal Name: Current Research in NeurobiologyPublisher: Elsevier BVVol: 4Issue #:Start Page: 100065End Page: 100065Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.crneur.2022.100065Best OA location URL: https://doi.org/10.1016/j.crneur.2022.100065Citation Count: 17
-
OPENTitle: Motor symptoms in Parkinson’s disease are related to the interplay between cortical curvature and thicknessJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 37Issue #:Start Page: 103300End Page: 103300Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103300Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103300Citation Count: 5